Nukkleus Liabilities And Stockholders Equity from 2010 to 2024

NUKK Stock  USD 0.86  0  0.23%   
Nukkleus Liabilities And Stockholders Equity yearly trend continues to be quite stable with very little volatility. Liabilities And Stockholders Equity may rise above about 22.2 M this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Nukkleus' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2014-03-31
Previous Quarter
15.3 M
Current Value
4.6 M
Quarterly Volatility
7.9 M
 
Yuan Drop
 
Covid
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.6 M, Selling General Administrative of 6.6 M or Selling And Marketing Expenses of 507.4 K, as well as many exotic indicators such as Price To Sales Ratio of 178, Ptb Ratio of 233 or Invested Capital of 0.32. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
This module can also supplement various Nukkleus Technical models . Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Latest Nukkleus' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Nukkleus over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Nukkleus' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Nukkleus Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean6,890,397
Geometric Mean0.00
Coefficient Of Variation134.08
Mean Deviation8,297,723
Median1,104,951
Standard Deviation9,238,517
Sample Variance85.4T
Range22.2M
R-Value0.87
Mean Square Error22.9T
R-Squared0.75
Significance0.00003
Slope1,789,625
Total Sum of Squares1194.9T

Nukkleus Liabilities And Stockholders Equity History

202422.2 M
202321.1 M
202118.4 M
202016.7 M
20193.8 M
2018203 K
2017305.8 K

About Nukkleus Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Nukkleus income statement, its balance sheet, and the statement of cash flows. Nukkleus investors use historical funamental indicators, such as Nukkleus's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Nukkleus investors may use each financial statement separately, they are all related. The changes in Nukkleus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nukkleus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Nukkleus Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Nukkleus. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity21.1 M22.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Nukkleus Stock analysis

When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Nukkleus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.061
Quarterly Revenue Growth
0.012
Return On Assets
(0.16)
Return On Equity
(0.75)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.